Drugmaker GlaxoSmithKline (GSK) and Comic Relief has formed a five-year partnership to reduce the global malaria burden by 2030. Comic relief and GSK has contributed £5m and £17m respectively for reducing malaria in five endemic countries in Sub-Saharan Africa and Asia.
The partnership aims to support the World Health Organization's target to cut malaria case incidence and mortality rates by 90% over the next 15 years and the Roll Back Malaria partnership's goal of a malaria-free world.
WHO strategy focuses on bolstering global and national programs to control malaria and increase access to diagnosis, prevention and treatment. There were an estimated 214 million new malaria cases and 438,000 deaths - 90% of which were in Africa in 2015.